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Abstract Curcumin, a polyphenol yellow orange pigment present in Indian spice ‘‘turmeric’’, is a member
of the ginger family (Zingiberaceae). The extract of turmeric was obtained by using soxhlet apparatus
at 45–55 °C, using methanol as solvent and then curcumin was isolated from methanolic extract by
column chromatography. In the present study, a series of four new derivatives of curcumin (3a–d)
were synthesized by reacting curcumin (1) with different alkyl halides (2a–d) using DMF and lithium
hydride. The structures of natural curcumin and its synthetic derivatives were confirmed with the help
of their 1H-NMR spectra and all these were screened against acetylcholinesterase, butyrylcholinesterase,
lipoxygenase and trypsin enzymes. Curcumin and its derivatives exhibited moderate inhibitory potential
against all aforesaid enzymes.
© 2012 Sharif University of Technology. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Curcumin is a yellow orange dietary pigment present in In-
dian spice ‘‘turmeric’’ and is responsible for the yellow color of
curry and good taste [1,2]. Curcumin, commonly called difer-
uloyl methane, is a hydrophobic natural polyphenol. It is also
known as ‘‘Natural Yellow 3’’ [3,4]. It is effectively used for
the recovery of many diseases including multiple myeloma,
Alzheimer’s disease, psoriasis, pancreatic cancer andmyelodys-
plastic syndrome [5]. It is very effective against HIV (human im-
munodeficiency virus, the AIDS virus), because curcumin has
ability to interfere with replication cycle of HIV [6,7]. Over
the centuries it has been used as anti-inflammatory agent to
relieve pain and inflammation in skin and muscle. It is also
used for the treatment of jaundice and menstrual disturbance.
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doi:10.1016/j.scient.2012.10.014It is an antioxidant, anti-inflammatory, anti-carcinogenic and
antimicrobial agent [8]. It has been used for thousand years
as a spice, coloring agent in foods, household medicines and
insect repellent [2]. It is also used to minimize the risk of
lung cancer associated with smoking. It reduces the effects
of nicotine (a strong cancer-causing agent) as a carcinogen
by 50% [9]. It showed efficient protective effect in reducing
the chances of cancer in lungs, liver, duodenum, and kidneys
[10,11]. In the present study, curcumin (1) was extracted from
turmeric using Soxhlet apparatus and then its O-substituted
derivatives were synthesized using different alkyl halides in
DMF. This natural curcumin (1) and its synthetic derivates
(3a–d) were screened against acetylcholinesterase (AChE), bu-
tyrylcholinesterase (BChE), lipoxygenase (LOX), and trypsin en-
zymes to investigate their inhibitory potential against these
enzymes.
2. Results and discussion
The synthesis of various derivatives of curcumin (1) has been
outlined in Scheme 1. The structure of the extracted curcumin
(1) was confirmed by it 1H-NMR spectrum showing the signals
at δ7.56 (d, J = 15.9 Hz, 2H, H-7, H-13), 7.19 (d, J = 1.2 Hz, 2H,
evier B.V. Open access under CC BY-NC-ND license.
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J = 8.1Hz, 2H, H-5 &H-5′), 6.59 (d, J = 15.6Hz, 2H, H-8, H-12),
5.95 (br s, H-10) and 3.88 (s, 6H, OCH3-1′′′,OCH3-1′′′′) in agree-
ment with reported literature [12]. In the 1H-NMR spectrum of
3a, in addition to the similar signal of curcumin, the additional
twoprotonmultiplet at δ4.58 (m, 2H, CH-1′′, CH-1′′′), and a dou-
blet at δ1.37 (d, J = 6.0Hz, 12H, CH3-2′′, CH3-3′′, CH3-2′′′, CH3-
3′′′) integrated for twelve protons, ascertained the substitution
of two O-iso propyl group at available positions C-4 and C-4′ in
the molecule. In 3b, the additional signals of 4.04 (t, J = 7.1 Hz,
4H, CH2-1′′, CH2-1′′′), 1.46 (sextet, J = 7.4 Hz, 4H, CH2-2′′, CH2-
2′′′), and 0.96 (t, J = 7.2 Hz, 6H, CH3-3′′, CH3-3′′′) confirmed the
substitution of two O− n-propyl groups at C-4 and C-4′ in this
molecule. In 3c, the additional signals at δ4.00 (t, J = 6.9Hz, 4H,
CH2-1′′, CH2-1′′′), 1.79 (quintet, J = 7.8 Hz, 4H, CH2-2′′, CH2-
2′′′), 1.48 (sextet, J = 7.5 Hz, 4H, CH2-3′′, CH2-3′′′) and 0.98 (t,
J = 7.5 Hz, 4H, CH3-4′′, CH3-4′′′) established the substitution of
two O − n-butyl groups at C-4 and C-4′ in this molecule. Simi-
larly, relative to 1, the substitution of two O− n-pentyl groups
was evident by the additional signals of 4.03 (t, J = 7.0 Hz,
4H, CH2-1′′, CH2-1′′′), 1.82 (m, 4H, CH2-2′′, CH2-2′′′), 1.41 (m,
4H, CH2-3′′, CH2-3′′′), 1.41 (m, 4H, CH2-4′′, CH2-4′′′), and 0.92 (t,
J = 7.3 Hz, 6H, CH3-5′′, CH3-5′′′) at positions C-4 and C-4′ in 3d.
The screening of natural 1 and its synthesized deriva-
tives 3a–d against AChE, BChE, LOX and protease enzymes re-
vealed that almost all these were moderately active against
all these enzymes except LOX (Table 1). The (1E,6E)-1,
7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
(Curcumin, 1) showed better activity having IC50 values of
58.08 ± 0.89 µmol/L for AChE, and 41.25 ± 0.79 µmol/L for
BChE, respectively, relative to its synthesized derivatives 3a–d.
However, these derivatives exhibited better inhibitory poten-
tial against trypsin enzyme as in this case, the highest IC50
(54.89± 0.78 µmol/L) was shown by 1. The IC50 against AChE
were found in the range between 58.08 ± 0.89 to 298.61 ±
0.95µmol/L, and the highest being shown by 3c. Against BChE,
it ranged between 41.25±0.79 to 143.2±0.93µmol/L, and thehighest being shown by 3a. However, against trypsin, 3b was
found to be a better inhibitor with IC50 of 19.36± 0.88µmol/L
relative to all other studied molecules. None of the derivative
exhibited antioxidant activity (maximum of 37.85%) or LOX in-
hibitory activity (maximum of 55%) at 0.5 mM concentration of
test compound.
2.1. Conclusion
In conclusion, it was inferred from the aforesaid enzyme
inhibitory results that the O-substituted synthetic derivatives




TLC was performed on pre-coated silica gel G-25-UV254
plates. Purity was checked with different solvent systems using
ethyl acetate and n-hexane giving single spot. 1H NMR spectra
were recorded in CDCl3 and CD3OD on a Bruker spectrometers
operating at 300 MHz. Chemical shifts are given in ppm. The
melting points were recorded on a Griffin & George melting
point apparatus.
3.2. General procedure for the extraction of curcumin from
turmeric
The extraction of curcumin (1)was carried out from turmeric
spice (1 kg) with methanol using Soxhlet apparatus as it is
simpler and more effective than other conventional extraction
methods [12]. The extraction was continued until the solvent
was found to be colourless. The dark brown methanolic
extract was obtained and was filtered and concentrated
by using a rotatory evaporator under reduced pressure at
50 °C. The dried crude methanolic extract was subjected to
extensive column chromatography using various compositions
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No.












1 85.70±0.95 115.21±0.87 96.50±0.97 58.08±0.89 97.80±0.99 41.25±0.79 41.21±0.78 >500 55.23±0.96 54.89± 0.78
3a 37.85±0.83 – 67.91±0.89 283.12±0.93 71.58±0.81 143.2±0.93 34.73±0.85 >500 57.32±0.79 32.96± 0.83
3b 7.59±0.94 – 68.84±0.97 279.12±0.98 73.90±0.88 141.9±0.97 55.45±0.93 >450 72.91±0.84 19.36± 0.88
3c 25.70±0.77 – 66.79±0.96 298.61±0.95 45.70±0.95 >500 50.42±0.89 >450 62.34±0.86 26.25± 0.82
3d 23.04±0.89 – 82.13±0.79 112.34±0.92 76.94±0.92 116.7±0.95 50.22±0.91 >450 51.45±0.81 41.81± 0.79
Control Quercetin 16.96±0.14 Eserine 0.04±0.001 Eserine 0.85±0.001 Baicalein 22.4± 1.3 PMSFb 0.11± 0.02
a 1,1-diphenyl-2-picrylhydrazyl radical.
b Phenylmethanesulfonyl fluoride.of n-hexane/dichloromethane and then dichloromethane/ethyl
acetate to get the purified 1 (1.98 g). Its purity was checked on
pre-coated thin layer chromatography (TLC) plate giving single
spot. The purity of the isolated curcumin was also obvious from
its clear 1H-NMR spectrum.
3.3. General procedure for the synthesis of 4-O, 4′-O-Di-alkyl
derivatives (3a–d) in DMF
Calculated amount of 1 (0.2 g; 0.000543 mol) was dissolved
in dimethyl formamide (DMF) in a round bottom flask (50 mL),
followed by the addition of lithium hydride (0.05 g). The
mixture was stirred for 30 min at room temperature, then
dimolar quantity (0.00109 mol) of the alkyl iodide, 2a–d, was
added and the solution was further stirred for three hours.
The progress of the reaction was monitored by TLC. After the
completion of the reaction, excess cold water was added to
the flask and it was shaken well. A semi-solid product formed
was subjected to solvent extraction with chloroform. The lower
organic layer was separated and dried to obtain the final
product.
3.4. DPPH radical scavenging activity
Compounds were assayed for antioxidant activity using
DPPH method. Ninty µL methanolic 0.1 mM DPPH solution
contained 10 µL of 0.5 mM test solution to give total volume
of 100 µL well−1. After 30 min of incubation at 30 °C, the loss
in absorbance was measured using Synergy HT (USA) 96-well
plate reader. Percent DPPH scavenging activity was calculated
by standard method.
3.5. AChE and BChE assay
The AChE and BChE inhibition activity were performed
according to the method of Ellman et al. [13] with slight
modifications. Total volumeof the reactionmixturewas 100µL.
It contained 60 µL Na2H PO4 buffer with concentration of 50
mM and pH 7.7. Ten µL test compound (0.5 mM well−1) was
added, followed by the addition of 10 µL (0.005 unit well−1)
enzyme. The contents were mixed and pre-read at 405 nm.
Then contents were pre-incubated for 10 min at 37 °C. The
reactionwas initiated by the addition of 10µL of 0.5mMwell−1
substrate (acetylthiocholine iodide), followed by the addition
of 10 µL DTNB (0.5 mM well−1). After 15 min of incubation at
37 °C, the absorbance was measured at 405 nm using Synergy
HT (USA) 96-well plate reader. All experiments were carried
out with their respective controls in triplicate. Eserine (0.5 mM
well−1) was used as a positive control. The percent inhibition
was calculated by the help of the following equation:Inhibition (%) = Control− Test
Control
× 100.
IC50 values (concentration at which there is 50% enzyme
inhibition) of compounds were calculated using EZ–Fit Enzyme
kinetics software (Perella Scientific Inc. Amherst, USA).
3.6. LOX assay
LOX activity was assayed according to themethod of Tappel,
Evans and Baylac and Racine [14–16] with slight modifications.
A total volume of 200 µL assay mixture contained 150 µL
sodium phosphate buffer (100 mM, pH 8.0), 10 µL test
compound and 15 µL purified LOX enzyme (Sigma). The
contentsweremixed andpre-read at 234nmandpre-incubated
for 10 min at 25 °C. The reaction was initiated by the addition
of 25 µL substrate solution. The change in absorbance was
observed after 6 min at 234 nm using Synergy HT (USA) 96-
well plate reader. All reactions were performed in triplicates.
Baicalein (0.5 mM well−1) was used as a positive control.
The percentage inhibition (%) was calculated by formula given
below. IC50 valueswere calculated using EZ–Fit Enzymekinetics
software (Perella Scientific Inc. Amherst, USA).
Inhibition(%) = Control− Test
Control
× 100
Control = Total enzyme activity without inhibitor
Test = Activity in the presence of test compound.
3.7. Trypsin inhibition assay
Trypsin inhibition assay was carried out according to the
method of Jedinak et al. [17] with somemodification. The stock
solution of trypsinwas prepared by dissolving 2mgof trypsin in
10mLof 1.0mMHCl. N-a-benzoyl-DL-arginine paranitroanilide
hydrochloride (BApNA) was dissolved in DMSO (20 mg/mL).
Enzyme (0.3 mL) and inhibitor (100 µL) was incubated at 37 °C
for 15 min then 0.6 mM substrate was added and final volume
was made 2.5 mL with Tris buffer (100 mM, pH 7.5). The
reaction mixture was incubated at 37 °C for 0.5 h. The reaction
was quenched by adding 30% acetic acid and read at 410
nm using spectrophotometer. PMSF (phenylmethanesulfonyl
fluoride) was used as positive reference. The percentage
inhibition was calculated by using the following formula:
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δ7.56 (d, J = 15.9 Hz, 2H, H-7, H-13), 7.19 (d, J = 1.2 Hz, 2H,
H-2 & H-2′), 7.08 (dd, J = 1.5, 8.1 Hz, 2H, H-6 & H-6′), 6.81 (d,
J = 8.1Hz, 2H, H-5 &H-5′), 6.59 (d, J = 15.6Hz, 2H, H-8, H-12),
5.95 (br s, H-10) and 3.88 (s, 2OCH3,OCH3-1′′′′, OCH3-1′′′′′).
4-O,4′-O-Di-isopropyl curcumin (3a)
Dark brown oily solid, yield 69%, 1H-NMR (300MHz, CDCl3):
δ7.58 (d, J = 15.6 Hz, H-7), 7.10 (dd, J = 1.6, 8.4 Hz, 2H, H-6 &
H-6′), 7.03 (d, J = 1.6 Hz, 2H, H-2 & H-2′), 6.85 (d, J = 8.4 Hz,
2H, H-5, H-5′), 6.47 (d, J = 15.9 Hz, H-8), 5.78 (br s, H-10), 4.58
(m, 2CH, CH2-1′′, CH-1′′′), 3.88 (s, 2OCH3, OCH3-1′′′′, OCH3-1′′′′′),
1.37 (d, J = 6.0, 12H, CH3-2′′, CH32′′′, CH3. 3′′, CH3-3′′′).
4-O, 4′-O-Di-n-propyl curcumin (3b)
Dark brown solid, yield 92%, 1H-NMR (300 MHz, CDCl3):
δ7.65 (d, J = 15.3 Hz, H-7), 7.12 (dd, J = 1.7, 8.1 Hz, 2H, H-6 &
H-6′), 6.95 (d, J = 1.7 Hz, 2H, H-2 & H-2′), 6.78 (d, J = 8.1 Hz,
2H, H-5 & H-5′), 6.59 (d, J = 15.6 Hz, H-8), 5.79 (br s, H-10),
4.04 (t, J = 7.1 Hz, 4H, CH2-1′′, CH2-1′′′), 3.88 (s, 2OCH3, OCH3-
1′′′′, OCH3-1′′′′′), 1.46 (sextet, J = 7.4 Hz, 4H, CH2-2′′, CH2-2′′′),
0.96 (t, J = 7.2 Hz, 6H, CH3-3′′, CH3-3′′′).
4-O, 4′-O-Di-n-butyl curcumin (3c)
Brownish solid, yield 57%, 1H-NMR (300 MHz, CDCl3): δ7.65
(d, J = 15.3 Hz, H-7), 7.07 (dd, J = 1.5, 8.4 Hz, 2H, H-6 & H-6′),
6.96 (d, J = 1.5 Hz, 2H, H-2 & H-2′), 6.79 (d, J = 8.4 Hz, 2H,
H-5 & H-5′), 6.59 (d, J = 15.6 Hz, H-8), 5.88 (br s, H-10), 4.00
(t, J = 6.9, 2CH2, CH2-1′′, CH2-1′′′), 3.84 (s, 2OCH3, OCH3-1′′′′,
OCH3-1′′′′′), 1.79 (quintet, J = 7.8 Hz, 2CH2, CH2-2′′, CH2-2′′′),
1.48 (sextet, J = 7.5 Hz, 4H, CH2-3′′, CH2-3′′′), 0.98 (t, J = 7.5,
6H, CH3-4′′, CH3-4′′′).
4-O, 4′-O-Di-n-pentyl curcumin (3d)
Yellowish solid, yield 78%, 1H-NMR (300MHz, CDCl3): δ7.65
(d, J = 15.3 Hz, H-7), 7.06 (dd, J = 1.6, 8.1 Hz, 2H, H-6 & H-6′),
6.97 (d, J = 1.6 Hz, 2H, H-2 & H-2′), 6.79 (d, J = 8.1 Hz, 2H,
H-5 & H-5′), 6.59 (d, J = 15.6 Hz, H-8), 5.86 (br s, H-10), 4.03
(t, J = 7.0 Hz, 2CH2, CH2-1′′, CH2-1′′′), 3.85(s, 2OCH3, OCH3-1′′′′,
OCH3-1′′′′′), 1.82 (m, 4H, CH2-2′′, CH2-2′′′), 1.41 (m, 4H, CH2-3′′,
CH2-3′′′), 1.41 (m, 4H, CH2-4′′, CH2-4′′′), 0.92 (t, J = 7.3, 6H,
CH3-5′′, CH3-5′′′).
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